These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 29316298)
1. Improving the Safety Assessment of Chemicals and Drug Candidates by the Integration of Bioinformatics and Chemoinformatics Data. Steger-Hartmann T; Pognan F Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():29-36. PubMed ID: 29316298 [TBL] [Abstract][Full Text] [Related]
2. Inroads to predict in vivo toxicology-an introduction to the eTOX Project. Briggs K; Cases M; Heard DJ; Pastor M; Pognan F; Sanz F; Schwab CH; Steger-Hartmann T; Sutter A; Watson DK; Wichard JD Int J Mol Sci; 2012; 13(3):3820-3846. PubMed ID: 22489185 [TBL] [Abstract][Full Text] [Related]
3. The eTOX data-sharing project to advance in silico drug-induced toxicity prediction. Cases M; Briggs K; Steger-Hartmann T; Pognan F; Marc P; Kleinöder T; Schwab CH; Pastor M; Wichard J; Sanz F Int J Mol Sci; 2014 Nov; 15(11):21136-54. PubMed ID: 25405742 [TBL] [Abstract][Full Text] [Related]
4. Legacy data sharing to improve drug safety assessment: the eTOX project. Sanz F; Pognan F; Steger-Hartmann T; Díaz C; ; Cases M; Pastor M; Marc P; Wichard J; Briggs K; Watson DK; Kleinöder T; Yang C; Amberg A; Beaumont M; Brookes AJ; Brunak S; Cronin MTD; Ecker GF; Escher S; Greene N; Guzmán A; Hersey A; Jacques P; Lammens L; Mestres J; Muster W; Northeved H; Pinches M; Saiz J; Sajot N; Valencia A; van der Lei J; Vermeulen NPE; Vock E; Wolber G; Zamora I Nat Rev Drug Discov; 2017 Dec; 16(12):811-812. PubMed ID: 29026211 [TBL] [Abstract][Full Text] [Related]
5. COSMOS next generation - A public knowledge base leveraging chemical and biological data to support the regulatory assessment of chemicals. Yang C; Cronin MTD; Arvidson KB; Bienfait B; Enoch SJ; Heldreth B; Hobocienski B; Muldoon-Jacobs K; Lan Y; Madden JC; Magdziarz T; Marusczyk J; Mostrag A; Nelms M; Neagu D; Przybylak K; Rathman JF; Park J; Richarz AN; Richard AM; Ribeiro JV; Sacher O; Schwab C; Vitcheva V; Volarath P; Worth AP Comput Toxicol; 2021 Aug; 19():100175. PubMed ID: 34405124 [TBL] [Abstract][Full Text] [Related]
6. Relevance and Application of Read-Across - Mini Review of European Consensus Platform for Alternatives and Scandinavian Society for Cell Toxicology 2017 Workshop Session. Stuard SB; Heinonen T Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():37-41. PubMed ID: 29524304 [TBL] [Abstract][Full Text] [Related]
7. Value of shared preclinical safety studies - The eTOX database. Briggs K; Barber C; Cases M; Marc P; Steger-Hartmann T Toxicol Rep; 2015; 2():210-221. PubMed ID: 28962354 [TBL] [Abstract][Full Text] [Related]
8. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling. Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223 [TBL] [Abstract][Full Text] [Related]
9. In silico toxicology for the pharmaceutical sciences. Valerio LG Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836 [TBL] [Abstract][Full Text] [Related]
10. Nontest Methods to Predict Acute Toxicity: State of the Art for Applications of In Silico Methods. Bureau R Methods Mol Biol; 2018; 1800():519-534. PubMed ID: 29934909 [TBL] [Abstract][Full Text] [Related]
11. Exploratory safety pharmacology: a new safety paradigm to de-risk drug candidates prior to selection for regulatory science investigations. Cavero I Expert Opin Drug Saf; 2009 Nov; 8(6):627-47. PubMed ID: 19998526 [TBL] [Abstract][Full Text] [Related]
12. In silico approaches to explore toxicity end points: issues and concerns for estimating human health effects. Matthews EJ; Contrera JF Expert Opin Drug Metab Toxicol; 2007 Feb; 3(1):125-34. PubMed ID: 17269899 [TBL] [Abstract][Full Text] [Related]
13. Application of in vitro neurotoxicity testing for regulatory purposes: Symposium III summary and research needs. Bal-Price AK; Suñol C; Weiss DG; van Vliet E; Westerink RH; Costa LG Neurotoxicology; 2008 May; 29(3):520-31. PubMed ID: 18417220 [TBL] [Abstract][Full Text] [Related]
14. The challenge of predicting drug toxicity in silico. Vedani A; Dobler M; Lill MA Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):195-208. PubMed ID: 16930291 [TBL] [Abstract][Full Text] [Related]
15. In silico ADMET prediction: recent advances, current challenges and future trends. Cheng F; Li W; Liu G; Tang Y Curr Top Med Chem; 2013; 13(11):1273-89. PubMed ID: 23675935 [TBL] [Abstract][Full Text] [Related]
16. Workshop: use of "read-across" for chemical safety assessment under REACH. Patlewicz G; Roberts DW; Aptula A; Blackburn K; Hubesch B Regul Toxicol Pharmacol; 2013 Mar; 65(2):226-8. PubMed ID: 23266660 [TBL] [Abstract][Full Text] [Related]
17. Neuroinformatics and Computational Modelling as Complementary Tools for Neurotoxicology Studies. Linne ML Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():56-61. PubMed ID: 29924904 [TBL] [Abstract][Full Text] [Related]
18. Assessment of the health effects of chemicals in humans: I. QSAR estimation of the maximum recommended therapeutic dose (MRTD) and no effect level (NOEL) of organic chemicals based on clinical trial data. Matthews EJ; Kruhlak NL; Benz RD; Contrera JF Curr Drug Discov Technol; 2004 Jan; 1(1):61-76. PubMed ID: 16472220 [TBL] [Abstract][Full Text] [Related]